So Jacobin is misleading, because the Finnish vaccine, while promising, is nowhere near the market. Testing has to yet begin on animals and then humans. Must read in the sense that the vaccine is a new mechanism, but otherwise way overblown reaction and interpretation from Jacobin… aleric One of the points of the article was that they were not able to get money allocated for human studies. Which are expensive, but a fraction of the total spent acquiring vaccine from other sources. So this criticism seems to miss the point that the state is unwilling to invest to break the oligopoly of big pharma.